Literature DB >> 11751126

Countrywide spread of CTX-M-3 extended-spectrum beta-lactamase-producing microorganisms of the family Enterobacteriaceae in Poland.

Anna Baraniak1, Janusz Fiett, Agnieszka Sulikowska, Waleria Hryniewicz, Marek Gniadkowski.   

Abstract

Eighty-four clinical isolates of the family Enterobacteriaceae, recovered from 1998 to 2000 in 15 hospitals in 10 Polish cities, were analyzed. All the isolates produced beta-lactamases with pIs of 8.4 and 5.4, and the pI 8.4 enzymes were demonstrated to hydrolyze cefotaxime but not ceftazidime in the in vitro bioassay. PCR analysis and DNA sequencing have revealed that in all cases the pI 8.4 beta-lactamase was probably the CTX-M-3 extended-spectrum beta-lactamase (ESBL) variant, which was originally identified in 1996 in Praski Hospital in Warsaw. In the majority of isolates, bla(CTX-M-3) genes resided within large conjugative plasmids with similar fingerprints, which, in the context of the high degree of diversity of the randomly amplified polymorphic DNA types of the isolates, suggested that horizontal transfer of plasmids was likely the main mechanism of CTX-M-3 spread. The dissemination of plasmids was probably preceded by the center-to-center transmission of several strains, as indicated by the identification by pulsed-field gel electrophoresis of closely related or possibly related Klebsiella pneumoniae, Escherichia coli, and Citrobacter freundii isolates in five different hospitals. CTX-M-3-producing organisms revealed a very high degree of diversity in beta-lactam resistance levels and patterns. This was attributed to several factors, such as the production of other beta-lactamases including additional ESBLs, possible quantitative variations in CTX-M-3 expression, segregation of AmpC derepressed mutants, and permeability alterations.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11751126      PMCID: PMC126981          DOI: 10.1128/AAC.46.1.151-159.2002

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  41 in total

1.  First isolation of a CTX-M-3-producing Enterobacter cloacae in France.

Authors:  F Doucet-Populaire; J C Ghnassia; R Bonnet; J Sirot
Journal:  Antimicrob Agents Chemother       Date:  2000-11       Impact factor: 5.191

2.  Epidemiology of extended spectrum beta-lactamases.

Authors:  A Philippon; S Ben Redjeb; G Fournier; A Ben Hassen
Journal:  Infection       Date:  1989 Sep-Oct       Impact factor: 3.553

3.  In vivo selection of a cephamycin-resistant, porin-deficient mutant of Klebsiella pneumoniae producing a TEM-3 beta-lactamase.

Authors:  B Pangon; C Bizet; A Buré; F Pichon; A Philippon; B Regnier; L Gutmann
Journal:  J Infect Dis       Date:  1989-05       Impact factor: 5.226

4.  Extended broad-spectrum beta-lactamases conferring transferable resistance to newer beta-lactam agents in Enterobacteriaceae: hospital prevalence and susceptibility patterns.

Authors:  V Jarlier; M H Nicolas; G Fournier; A Philippon
Journal:  Rev Infect Dis       Date:  1988 Jul-Aug

5.  Concurrent outbreaks of extended-spectrum beta-lactamase-producing organisms of the family Enterobacteriaceae in a Warsaw hospital.

Authors:  A Pałucha; B Mikiewicz; W Hryniewicz; M Gniadkowski
Journal:  J Antimicrob Chemother       Date:  1999-10       Impact factor: 5.790

Review 6.  A functional classification scheme for beta-lactamases and its correlation with molecular structure.

Authors:  K Bush; G A Jacoby; A A Medeiros
Journal:  Antimicrob Agents Chemother       Date:  1995-06       Impact factor: 5.191

7.  Typing of Pseudomonas aeruginosa strains from patients with cystic fibrosis: phenotyping versus genotyping.

Authors:  Nicole Renders; Alex van Belkum; Alfonso Barth; Wil Goessens; Johan Mouton; Henri Verbrugh
Journal:  Clin Microbiol Infect       Date:  1996-06       Impact factor: 8.067

8.  Pseudomonas aeruginosa and Enterobacteriaceae bacteremia after biliary endoscopy: an outbreak investigation using DNA macrorestriction analysis.

Authors:  M J Struelens; F Rost; A Deplano; A Maas; V Schwam; E Serruys; M Cremer
Journal:  Am J Med       Date:  1993-11       Impact factor: 4.965

9.  Molecular epidemiology of Klebsiella pneumoniae strains that produce SHV-4 beta-lactamase and which were isolated in 14 French hospitals.

Authors:  G Arlet; M Rouveau; I Casin; P J Bouvet; P H Lagrange; A Philippon
Journal:  J Clin Microbiol       Date:  1994-10       Impact factor: 5.948

10.  Cloning and sequence of the gene encoding a cefotaxime-hydrolyzing class A beta-lactamase isolated from Escherichia coli.

Authors:  Y Ishii; A Ohno; H Taguchi; S Imajo; M Ishiguro; H Matsuzawa
Journal:  Antimicrob Agents Chemother       Date:  1995-10       Impact factor: 5.191

View more
  41 in total

1.  Molecular characteristics of KPC-producing Enterobacteriaceae at the early stage of their dissemination in Poland, 2008-2009.

Authors:  Anna Baraniak; Anna Grabowska; Radosław Izdebski; Janusz Fiett; Małgorzata Herda; Katarzyna Bojarska; Dorota Żabicka; Marta Kania-Pudło; Grazyna Młynarczyk; Zofia Żak-Puławska; Waleria Hryniewicz; Marek Gniadkowski
Journal:  Antimicrob Agents Chemother       Date:  2011-09-19       Impact factor: 5.191

Review 2.  Growing group of extended-spectrum beta-lactamases: the CTX-M enzymes.

Authors:  R Bonnet
Journal:  Antimicrob Agents Chemother       Date:  2004-01       Impact factor: 5.191

3.  Clinical isolates of Enterobacteriaceae producing extended-spectrum beta-lactamases: prevalence of CTX-M-3 at a hospital in China.

Authors:  Hui Wang; Swathi Kelkar; Weiyuan Wu; Minjun Chen; John P Quinn
Journal:  Antimicrob Agents Chemother       Date:  2003-02       Impact factor: 5.191

4.  Evaluation of the BD Phoenix automated identification and susceptibility testing system in clinical microbiology laboratory practice.

Authors:  E Stefaniuk; A Baraniak; M Gniadkowski; W Hryniewicz
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2003-07-18       Impact factor: 3.267

5.  The role of horizontal gene transfer in the dissemination of extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae isolates in an endemic setting.

Authors:  Yohei Doi; Jennifer M Adams-Haduch; Anton Y Peleg; Erika M C D'Agata
Journal:  Diagn Microbiol Infect Dis       Date:  2012-06-20       Impact factor: 2.803

6.  Phenotypic and molecular detection of CTX-M-beta-lactamases produced by Escherichia coli and Klebsiella spp.

Authors:  Johann D D Pitout; Ashfaque Hossain; Nancy D Hanson
Journal:  J Clin Microbiol       Date:  2004-12       Impact factor: 5.948

7.  Detection of cefotaxime-resistant CTX-M-3 in clinical isolates of Serratia marcescens.

Authors:  Mei-Fen Tsou; Wen-Liang Yu; Siu Wan Hung; Chizh-Ju Chi; Ssu Ching Chen; Lii-Tzu Wu
Journal:  Folia Microbiol (Praha)       Date:  2004       Impact factor: 2.099

8.  Prevalence of derepressed ampC mutants and extended-spectrum beta-lactamase producers among clinical isolates of Citrobacter freundii, Enterobacter spp., and Serratia marcescens in Korea: dissemination of CTX-M-3, TEM-52, and SHV-12.

Authors:  Jungmin Kim; Yu-Mi Lim
Journal:  J Clin Microbiol       Date:  2005-05       Impact factor: 5.948

Review 9.  Trends in human fecal carriage of extended-spectrum β-lactamases in the community: toward the globalization of CTX-M.

Authors:  Paul-Louis Woerther; Charles Burdet; Elisabeth Chachaty; Antoine Andremont
Journal:  Clin Microbiol Rev       Date:  2013-10       Impact factor: 26.132

10.  Molecular survey of beta-lactamases conferring resistance to newer beta-lactams in Enterobacteriaceae isolates from Polish hospitals.

Authors:  Joanna Empel; Anna Baraniak; Elzbieta Literacka; Agnieszka Mrówka; Janusz Fiett; Ewa Sadowy; Waleria Hryniewicz; Marek Gniadkowski
Journal:  Antimicrob Agents Chemother       Date:  2008-05-05       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.